Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLoans - NetLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Enovix (ENVX) Cash & Equivalents (2020 - 2025)

Historic Cash & Equivalents for Enovix (ENVX) over the last 6 years, with Q3 2025 value amounting to $335.5 million.

  • Enovix's Cash & Equivalents rose 6698.95% to $335.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $335.5 million, marking a year-over-year increase of 6698.95%. This contributed to the annual value of $272.9 million for FY2024, which is 1705.04% up from last year.
  • Per Enovix's latest filing, its Cash & Equivalents stood at $335.5 million for Q3 2025, which was up 6698.95% from $136.0 million recorded in Q2 2025.
  • In the past 5 years, Enovix's Cash & Equivalents registered a high of $408.2 million during Q2 2022, and its lowest value of $5.0 million during Q2 2021.
  • In the last 5 years, Enovix's Cash & Equivalents had a median value of $272.9 million in 2024 and averaged $260.0 million.
  • As far as peak fluctuations go, Enovix's Cash & Equivalents skyrocketed by 767075.34% in 2022, and later crashed by 4216.24% in 2025.
  • Enovix's Cash & Equivalents (Quarter) stood at $338.7 million in 2021, then grew by 3.03% to $349.0 million in 2022, then plummeted by 33.2% to $233.1 million in 2023, then grew by 17.05% to $272.9 million in 2024, then increased by 22.95% to $335.5 million in 2025.
  • Its Cash & Equivalents stands at $335.5 million for Q3 2025, versus $136.0 million for Q2 2025 and $189.9 million for Q1 2025.